Operations

Andy Molnar, CEO of the Digital Therapeutics Alliance, and Scott Stuewe, president and CEO of DirectTrust, discuss their partnership to show digital therapeutics' value and accreditation in healthcare for payors considering DTx coverage.  

Dr. Calum Yacoubian, director of NLP healthcare strategy at IQVIA, says AI can support, not replace, clinicians in improving care delivery, and discusses some best practices for its safe and ethical use. The HIMSS AI in Healthcare Forum is scheduled to take place September 5-6 in Boston. Learn more and register.  

Kyruus Health president Paul Merrild discusses how the company aims to improve care access via its partnerships with health systems and payers and by pairing patients and providers using personalized information and provider availability.  

Robert Latz, CIO of Trinity Rehabilitation Services, discusses nursing homes' increased use of digital tools like automated cameras and how the HIMSS LTPAC committee is developing a prioritization tool to help facilities decide which tools to deploy.  

Cole Wiser, executive creative director at the Virtual Wild, and Srini Iyer, chief technology officer for Leidos' health and civil sector, discuss using holograms for immersive training and patient interactions.  

Oscar Alleyne, managing director of the public health division at MITRE, relays how federally funded research and development centers help public and private companies solve complex problems, including preparing for the next pandemic.  

Dr. Guido Giunti discusses patient involvement and the necessity of being forward-thinking in creating digital therapeutics.

The ONC's new rules could include advancements around public health IT certification requirements, electronic prior authorization, patient engagement tools and refinement to info blocking rules, says Sean Sullivan, a partner at Alston & Bird.  

David Wolf, MedeAnalytics AVP, and Lynn Carroll, HSBlox COO, highlight value-based care models' crucial components, including contract modeling and performance measurement, and discuss change management for switching to these models.  

Dr. John Showalter, Linus' chief product officer, discusses the company's cognitive impairment testing and care-delivery offerings for dementia diagnosis and treatment and its acquisition of speech analytics platform Aural Analytics.